Established in November 2020, Guangdong Zhaotai Cell Biotechnology Co., Ltd. focuses on a range of business activities, including general projects like medical research and experimental development; the research and development as well as application of cell technology; and providing technological services, technology development, and technological consultancy.

Disease Domain	Count

Neoplasms	2

Top 5 Drug Type	Count

Universal CAR-T	1
Bispecific antibody	1

Top 5 Target	Count

IL-23 x MSLN	1
TGF-β1(Transforming growth factor beta 1)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 15 Jan 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Early Phase 1

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

Allogeneic anti-TGFB CAR-T (Guangdong Zhaotai Cell ) ( TGF-β1 )	Non-Small Cell Lung Cancer More	Early Phase 1
CN117866105 ( IL-23 x MSLN )Patent Mining	Neoplasms More	Discovery
CD19 CAR T-cell(Guangdong Zhaotai Cell Bio-tech Co., LTD) ( CD19 )	CD19-positive B-cell acute lymphoblastic leukemia More	Discontinued

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis